At the news
? NEUTRALIMPACT 2/10 3 filed Jul 13, 2026 at 14:21 ET
HRT Financial LP filed a Form 3 initial statement of beneficial ownership, disclosing direct ownership of 60,540 shares of Shuttle Pharmaceuticals Holdings, Inc. This is a routine disclosure of a new beneficial owner and does not reflect any transaction or change in company operations.
- HRT Financial LP filed Form 3 on July 13, 2026, with a period of report of July 9, 2026.
- HRT Financial LP directly owns 60,540 shares of Shuttle Pharmaceuticals common stock.
- No other securities or derivative instruments were reported.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access